<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=iso-8859-2"><meta name=Generator content="Microsoft Word 15 (filtered medium)"><!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Garamond;
panose-1:2 2 4 4 3 3 1 1 8 3;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin-top:0cm;
margin-right:0cm;
margin-bottom:8.0pt;
margin-left:0cm;
line-height:105%;
font-size:11.0pt;
font-family:"Calibri",sans-serif;
mso-fareast-language:EN-US;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:#0563C1;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:#954F72;
text-decoration:underline;}
p.MsoNoSpacing, li.MsoNoSpacing, div.MsoNoSpacing
{mso-style-priority:1;
margin:0cm;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri",sans-serif;
mso-fareast-language:EN-US;}
p.msonormal0, li.msonormal0, div.msonormal0
{mso-style-name:msonormal;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
span.E-potniSlog19
{mso-style-type:personal;
font-family:"Garamond",serif;
color:windowtext;}
span.E-potniSlog20
{mso-style-type:personal;
font-family:"Garamond",serif;
color:windowtext;}
span.E-potniSlog21
{mso-style-type:personal;
font-family:"Garamond",serif;
color:windowtext;}
span.E-potniSlog22
{mso-style-type:personal;
font-family:"Garamond",serif;
color:windowtext;}
span.E-potniSlog23
{mso-style-type:personal;
font-family:"Garamond",serif;
color:windowtext;}
span.E-potniSlog24
{mso-style-type:personal;
font-family:"Garamond",serif;
color:windowtext;}
span.E-potniSlog25
{mso-style-type:personal;
font-family:"Garamond",serif;
color:windowtext;}
span.E-potniSlog26
{mso-style-type:personal;
font-family:"Garamond",serif;
color:windowtext;}
span.E-potniSlog27
{mso-style-type:personal-compose;
font-family:"Garamond",serif;
color:windowtext;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:70.85pt 70.85pt 70.85pt 70.85pt;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=SL link="#0563C1" vlink="#954F72"><div class=WordSection1><p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:justify;line-height:normal;background:white'><span lang=EN-US><a href="https://bioendocar.eu/final-symposium-basic-information/"><span lang=SL style='font-size:12.0pt;font-family:"Times New Roman",serif;color:windowtext;mso-fareast-language:SL;text-decoration:none'><img border=0 width=610 height=232 style='width:6.3541in;height:2.4166in' id="Slika_x0020_1" src="cid:image002.png@01D8087C.8CF80120"></span></a></span><span style='font-size:12.0pt;font-family:"Times New Roman",serif;mso-fareast-language:SL'><o:p></o:p></span></p><p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:justify;line-height:normal;background:white'><span style='font-size:12.0pt;font-family:"Times New Roman",serif;mso-fareast-language:SL'><o:p> </o:p></span></p><p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:justify;line-height:normal;background:white'><span style='font-size:12.0pt;font-family:"Garamond",serif;mso-fareast-language:SL'>Spoštovani!<o:p></o:p></span></p><p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:justify;line-height:normal;background:white'><span style='font-size:12.0pt;font-family:"Garamond",serif;mso-fareast-language:SL'><o:p> </o:p></span></p><p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:justify;line-height:normal;background:white'><span style='font-size:12.0pt;font-family:"Garamond",serif;mso-fareast-language:SL'>Obveščamo vas, da smo do 20. marca 2022 podaljšali rok za </span><b><span style='font-size:12.0pt;font-family:"Garamond",serif'><a href="https://bioendocar.eu/final-symposium-registration/"><span style='mso-fareast-language:SL'>registracijo</span></a></span></b><span style='font-size:12.0pt;font-family:"Garamond",serif;mso-fareast-language:SL'> za udeležbo na <b>zaključnem srečanju projekta ERA-NET Transcan2</b> </span><b><span style='font-size:12.0pt;font-family:"Garamond",serif'><a href="https://bioendocar.eu"><span style='mso-fareast-language:SL'>BioEndoCar</span></a></span></b><span style='font-size:12.0pt;font-family:"Garamond",serif;mso-fareast-language:SL'>, ki ga koordinira UL MF. Udeležba na srečanju je brezplačna. <o:p></o:p></span></p><p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:justify;line-height:normal;background:white'><span style='font-size:12.0pt;font-family:"Garamond",serif;mso-fareast-language:SL'><o:p> </o:p></span></p><p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:justify;line-height:normal;background:white'><span style='font-size:12.0pt;font-family:"Garamond",serif;mso-fareast-language:SL'>Dvodnevni dogodek bo potekal <b>24. in 25. marca 2022</b> v Portorožu ter preko spleta in je namenjen zdravnikom in raziskovalcem, ki jih zanimajo translacijske raziskave. Srečanje se bo osredotočilo na klinične izzive pri zdravljenju raka endometrija, nove možnosti diagnostike in napovedi prognoze, proteomske in metabolomske pristope za odkrivanje biooznačevalcev za personalizirano zdravljenje, pomen biobank in eksperimentalne modele: od celičnih linij, 3D kultur do organoidov. Srečanje bo potekalo v okviru osmih sekcij in bo vključevalo 28 vabljenih predavanj predavateljev z Nizozemske, Nemčije, Norveške, Poljske, Češke, Italije, Estonije, Španije in Slovenije, zaključilo pa se bo s plenarnim predavanjem dr. Hanny Pijnenborg, predsednice Evropske mreže za individualizirano zdravljenje raka endometrija (</span><b><span style='font-size:12.0pt;font-family:"Garamond",serif'><a href="https://www.esgo.org/network/enitec/"><span style='mso-fareast-language:SL'>ENITEC</span></a></span></b><span style='font-size:12.0pt;font-family:"Garamond",serif;mso-fareast-language:SL'>). <o:p></o:p></span></p><p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:justify;line-height:normal;background:white'><span style='font-size:12.0pt;font-family:"Garamond",serif'><o:p> </o:p></span></p><p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:justify;line-height:normal;background:white'><span style='font-size:12.0pt;font-family:"Garamond",serif'>Srečanje je pridobilo 15 <span style='color:black;background:white'>kreditnih točk Zdravniške zbornice Slovenije</span></span><span style='font-size:12.0pt;font-family:"Garamond",serif;mso-fareast-language:SL'>. Več informacij o srečanju najdete na </span><b><span style='font-size:12.0pt;font-family:"Garamond",serif'><a href="https://bioendocar.eu/final-symposium-basic-information/"><span style='mso-fareast-language:SL'>spletni strani srečanja</span></a></span></b><span style='font-size:12.0pt;font-family:"Garamond",serif;mso-fareast-language:SL'>.<span style='background:yellow;mso-highlight:yellow'><o:p></o:p></span></span></p><p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:justify;line-height:normal;background:white'><span style='font-size:12.0pt;font-family:"Garamond",serif;mso-fareast-language:SL'><o:p> </o:p></span></p><p class=MsoNormal style='text-align:justify'><span style='font-size:12.0pt;line-height:105%;font-family:"Garamond",serif'>Organizacijski odbor<o:p></o:p></span></p><p class=MsoNoSpacing><o:p> </o:p></p><p class=MsoNormal><img border=0 width=415 height=63 style='width:4.3229in;height:.6562in' id="Picture_x0020_4" src="cid:image001.jpg@01D83875.E035A210"><img border=0 width=177 height=61 style='width:1.8437in;height:.6354in' id="Slika_x0020_3" src="cid:image003.png@01D83875.E035A210" alt="MIZŠ-logo - Fakulteta za varnostne vede"><span style='font-size:12.0pt;line-height:105%;font-family:"Garamond",serif'><o:p></o:p></span></p></div></body></html>